Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
216.91 USD | +1.31% | +2.31% | +5.87% |
Dec. 01 | Will Powell deliver an early Christmas present? | ![]() |
Dec. 01 | ANALYST RECOMMENDATIONS : Abbvie, Boeing, IBM, Lululemon Athletica, Meta Platforms... | ![]() |
Valuation
Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 23 239 | 29 981 | 34 352 | 53 900 | 38 056 | 39 586 | - | - |
Enterprise Value (EV) 1 | 33 355 | 40 789 | 44 983 | 64 659 | 49 587 | 51 417 | 50 665 | 50 036 |
P/E ratio | 93,7x | 161x | 125x | 57,0x | 35,8x | 33,3x | 29,6x | 24,0x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 2,23x | 2,70x | 3,02x | 3,88x | 2,64x | 2,66x | 2,54x | 2,36x |
EV / Revenue | 3,20x | 3,68x | 3,96x | 4,66x | 3,44x | 3,45x | 3,25x | 2,98x |
EV / EBITDA | 15,0x | 17,0x | 18,9x | 21,4x | 14,8x | 14,4x | 13,3x | 12,1x |
EV / FCF | 42,0x | 48,8x | 33,5x | 28,1x | 31,3x | 32,3x | 27,3x | 23,9x |
FCF Yield | 2,38% | 2,05% | 2,99% | 3,56% | 3,20% | 3,10% | 3,66% | 4,19% |
Price to Book | 3,50x | 4,95x | 5,71x | 9,11x | 6,60x | 6,47x | 5,55x | 4,92x |
Nbr of stocks (in thousands) | 200 046 | 194 038 | 191 726 | 191 040 | 185 740 | 182 500 | - | - |
Reference price 2 | 116 | 155 | 179 | 282 | 205 | 217 | 217 | 217 |
Announcement Date | 02/14/19 | 02/12/20 | 02/10/21 | 02/15/22 | 02/10/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 10 412 | 11 088 | 11 359 | 13 874 | 14 410 | 14 902 | 15 603 | 16 789 |
EBITDA 1 | 2 224 | 2 400 | 2 384 | 3 022 | 3 346 | 3 565 | 3 802 | 4 134 |
EBIT 1 | 1 946 | 2 112 | 2 030 | 2 591 | 2 779 | 3 027 | 3 238 | 3 542 |
Operating Margin | 18,7% | 19,0% | 17,9% | 18,7% | 19,3% | 20,3% | 20,8% | 21,1% |
Earnings before Tax (EBT) 1 | 328 | 352 | 373 | 1 128 | 1 363 | 1 519 | 1 705 | 2 045 |
Net income 1 | 259 | 191 | 279 | 966 | 1 091 | 1 225 | 1 361 | 1 637 |
Net margin | 2,49% | 1,72% | 2,46% | 6,96% | 7,57% | 8,22% | 8,72% | 9,75% |
EPS 2 | 1,24 | 0,96 | 1,43 | 4,95 | 5,72 | 6,52 | 7,33 | 9,02 |
Free Cash Flow 1 | 795 | 835 | 1 343 | 2 302 | 1 586 | 1 594 | 1 856 | 2 095 |
FCF margin | 7,64% | 7,53% | 11,8% | 16,6% | 11,0% | 10,7% | 11,9% | 12,5% |
FCF Conversion (EBITDA) | 35,7% | 34,8% | 56,3% | 76,2% | 47,4% | 44,7% | 48,8% | 50,7% |
FCF Conversion (Net income) | 307% | 437% | 481% | 238% | 145% | 130% | 136% | 128% |
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Announcement Date | 14/02/19 | 12/02/20 | 10/02/21 | 15/02/22 | 10/02/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period : December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 3 438 | 3 391 | 3 636 | 3 568 | 3 541 | 3 562 | 3 739 | 3 652 | 3 728 | 3 736 | 3 785 | 3 786 | 3 871 | 3 932 | 4 020 |
EBITDA 1 | 722 | 728 | 828 | 812 | 800 | 814 | 920 | 851 | 864 | 888 | 961 | 893 | 929 | 956 | 1 029 |
EBIT 1 | 618 | 623 | 704 | 691 | 682 | 694 | 712 | 721 | 737 | 747 | 821 | 757 | 789 | 812 | 879 |
Operating Margin | 18,0% | 18,4% | 19,4% | 19,4% | 19,3% | 19,5% | 19,0% | 19,7% | 19,8% | 20,0% | 21,7% | 20,0% | 20,4% | 20,7% | 21,9% |
Earnings before Tax (EBT) 1 | 222 | 273 | 376 | 400 | 328 | 360 | 275 | 362 | 375 | 349 | 432 | 363 | 415 | 411 | 489 |
Net income 1 | 175 | 261 | 318 | 325 | 256 | 283 | 227 | 289 | 297 | 303 | 331 | 284 | 318 | 330 | 390 |
Net margin | 5,09% | 7,70% | 8,75% | 9,11% | 7,23% | 7,94% | 6,07% | 7,91% | 7,97% | 8,11% | 8,75% | 7,50% | 8,22% | 8,40% | 9,69% |
EPS 2 | 0,90 | 1,34 | 1,63 | 1,68 | 1,34 | 1,49 | 1,20 | 1,53 | 1,59 | 1,63 | 1,75 | 1,54 | 1,74 | 1,81 | 2,14 |
Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 07/27/21 | 10/21/21 | 02/15/22 | 04/27/22 | 07/21/22 | 10/26/22 | 02/10/23 | 04/27/23 | 08/01/23 | 11/01/23 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 10 116 | 10 808 | 10 631 | 10 759 | 11 531 | 11 831 | 11 079 | 10 450 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 4,55x | 4,50x | 4,46x | 3,56x | 3,45x | 3,32x | 2,91x | 2,53x |
Free Cash Flow 1 | 795 | 835 | 1 343 | 2 302 | 1 586 | 1 594 | 1 856 | 2 095 |
ROE (net income / shareholders' equity) | 15,7% | 20,1% | 20,9% | 29,2% | 32,8% | 31,9% | 31,0% | 32,4% |
Shareholders' equity 1 | 1 648 | 952 | 1 337 | 3 305 | 3 325 | 3 843 | 4 388 | 5 051 |
ROA (Net income/ Total Assets) | 5,09% | 5,57% | 1,17% | 7,15% | 7,74% | 6,04% | 6,48% | 7,36% |
Assets 1 | 5 087 | 3 428 | 23 907 | 13 517 | 14 088 | 20 285 | 20 999 | 22 226 |
Book Value Per Share 2 | 33,2 | 31,2 | 31,4 | 31,0 | 31,0 | 33,5 | 39,1 | 44,1 |
Cash Flow per Share 2 | 6,02 | 7,10 | 10,0 | 15,1 | 11,9 | 12,7 | 14,6 | 16,2 |
Capex 1 | 459 | 582 | 616 | 640 | 674 | 642 | 662 | 711 |
Capex / Sales | 4,41% | 5,25% | 5,42% | 4,61% | 4,68% | 4,31% | 4,25% | 4,23% |
Announcement Date | 02/14/19 | 02/12/20 | 02/10/21 | 02/15/22 | 02/10/23 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
BUY
Number of Analysts
21
Last Close Price
216.91USD
Average target price
229.52USD
Spread / Average Target
+5.81%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.87% | 39 586 M $ | |
+65.53% | 40 132 M $ | |
-55.56% | 30 438 M $ | |
-26.11% | 28 571 M $ | |
+38.66% | 22 175 M $ | |
-27.87% | 21 511 M $ | |
+1.62% | 17 412 M $ | |
-13.43% | 11 313 M $ | |
-7.44% | 10 346 M $ | |
-22.08% | 10 212 M $ |
- Stock
- Equities
- Stock Iqvia Holdings Inc. - Nyse
- Financials Iqvia Holdings Inc.